The Comparative Advantage of Medicare Advantage.


Journal

American journal of health economics
ISSN: 2332-3493
Titre abrégé: Am J Health Econ
Pays: United States
ID NLM: 101666934

Informations de publication

Date de publication:
2019
Historique:
entrez: 30 4 2019
pubmed: 30 4 2019
medline: 30 4 2019
Statut: ppublish

Résumé

We ascertain the degree of service-level selection in Medicare Advantage (MA) using individual level data on the 100 most frequent HCC's or combination of HCC's from two national insurers in 2012-2013. We find differences in the distribution of beneficiaries across HCC's between TM and MA, principally in the smaller share of MA enrollees with no coded HCC, consistent with greater coding intensity in MA. Among those with an HCC code, absolute differences between MA and TM shares of beneficiaries are small, consistent with little service-level selection. Variation in HCC margins does not predict differences between an HCC's share of MA and TM enrollees, although one cannot a priori sign a relationship between margin and service-level selection. Margins are negatively associated with the importance of post-acute care in the HCC. Margins among common chronic disease classes amenable to medical management and typically managed by primary care physicians are larger than among diseases typically managed by specialists. These margin differences by disease are robust against a test for coding effects and suggest that the average technical efficiency of MA relative to TM may vary by diagnosis. If so, service-level selection on the basis of relative technical efficiency could be welfare enhancing.

Identifiants

pubmed: 31032383
pmc: PMC6481953
mid: NIHMS1019134

Types de publication

Journal Article

Langues

eng

Pagination

281-301

Subventions

Organisme : NIA NIH HHS
ID : P01 AG032952
Pays : United States

Références

J Health Econ. 2017 Dec;56:256-258
pubmed: 29248055
J Health Econ. 2016 May;47:1-19
pubmed: 26922122
Am Econ J Econ Policy. 2019 May;11(2):64-107
pubmed: 34012503
J Health Econ. 2017 Dec;56:234-236
pubmed: 28969868
Res Brief. 2013 Sep;(27):1-10
pubmed: 24073466
N Engl J Med. 2013 Apr 18;368(16):1465-8
pubmed: 23520983
Milbank Q. 2014 Jun;92(2):351-94
pubmed: 24890251
J Health Econ. 2013 Dec;32(6):1278-88
pubmed: 24308879
J Econ Perspect. 2011 Winter;25(1):115-38
pubmed: 21595322
Am Econ Rev. 2014 Oct;104(10):3335-64
pubmed: 29533567
JAMA. 2014 Oct 22-29;312(16):1653-62
pubmed: 25335147
J Polit Econ. 2017 Feb;125(1):1-39
pubmed: 28713176
Health Care Financ Rev. 2004 Summer;25(4):119-41
pubmed: 15493448
Am J Health Econ. 2015 Winter;1(1):1-26
pubmed: 26389127
J Health Econ. 2018 Sep;61:93-110
pubmed: 30099218
J Polit Econ. 2020 Mar;12(3):984-1026
pubmed: 32719571
Health Aff (Millwood). 2015 Oct;34(10):1753-60
pubmed: 26438753
J Econ Perspect. 2017;31(4):23-50
pubmed: 29465215
J Health Econ. 2000 Nov;19(6):829-54
pubmed: 11186848
Q J Econ. 2010 Aug 1;125(3):877-921
pubmed: 21218182
JAMA Intern Med. 2014 Jul;174(7):1067-76
pubmed: 24819824
Q J Econ. 2019 Feb;134(1):51-107
pubmed: 32981974

Auteurs

Joseph P Newhouse (JP)

Department of Health Care Policy, Harvard Medical School, Harvard University, Boston.

Mary Beth Landrum (MB)

Department of Health Care Policy, Harvard Medical School, Harvard University, Boston.

Mary Price (M)

Biostat Data Consulting, Inc.

J Michael McWilliams (JM)

Department of Health Care Policy, Harvard Medical School, Harvard University and Department of Medicine, Brigham and Women's Hospital, Boston.

John Hsu (J)

Mongan Institute for Health Care Policy, Massachusetts General Hospital and Department of Health Care Policy, Harvard Medical School, Harvard University, Boston.

Thomas G McGuire (TG)

Department of Health Care Policy, Harvard Medical School, Harvard University.

Classifications MeSH